|
Final Law Kicks Out Program for Track-and-Trace
Despite pharma stakeholder support for a track-and-trace program, consensus could not be reached on a method for implementing a U.S. system so the requirement was dropped from the final bill reauthorizing the Prescription Drug User Fee Act (PDUFA) due to resistance from some members of the drug industry and dickering over the language of the provision.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives